Correlation Between Cochlear and Actinogen Medical

Can any of the company-specific risk be diversified away by investing in both Cochlear and Actinogen Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cochlear and Actinogen Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cochlear and Actinogen Medical, you can compare the effects of market volatilities on Cochlear and Actinogen Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cochlear with a short position of Actinogen Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cochlear and Actinogen Medical.

Diversification Opportunities for Cochlear and Actinogen Medical

0.06

Correlation Coefficient

Cochlear  Actinogen Medical

Significant diversification

The 3 months correlation between Cochlear and Actinogen is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cochlear and Actinogen Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinogen Medical and Cochlear is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cochlear are associated (or correlated) with Actinogen Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinogen Medical has no effect on the direction of Cochlear i.e., Cochlear and Actinogen Medical go up and down completely randomly.

Pair Corralation between Cochlear and Actinogen Medical

Assuming the 90 days trading horizon Cochlear is expected to generate 0.26 times more return on investment than Actinogen Medical. However, Cochlear is 3.9 times less risky than Actinogen Medical. It trades about 0.03 of its potential returns per unit of risk. Actinogen Medical is currently generating about -0.03 per unit of risk. If you would invest  28,866  in Cochlear on September 12, 2024 and sell it today you would earn a total of  478.00  from holding Cochlear or generate 1.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Cochlear  vs.  Actinogen Medical

Cochlear

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cochlear are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical indicators, Cochlear is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Actinogen Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Cochlear and Actinogen Medical

The main advantage of trading using opposite Cochlear and Actinogen Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cochlear position performs unexpectedly, Actinogen Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will offset losses from the drop in Actinogen Medical's long position.

The idea behind Cochlear and Actinogen Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.